Detalhe da pesquisa
1.
Phase separation of FSP1 promotes ferroptosis.
Nature
; 619(7969): 371-377, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380771
2.
A non-canonical vitamin K cycle is a potent ferroptosis suppressor.
Nature
; 608(7924): 778-783, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35922516
3.
DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition.
Nature
; 619(7968): E9-E18, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407687
4.
Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05.
Osteoporos Int
; 34(1): 189-199, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239756
5.
Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene.
Calcif Tissue Int
; 112(4): 430-439, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707436
6.
The mitochondrial Ca2+ uptake regulator, MICU1, is involved in cold stress-induced ferroptosis.
EMBO Rep
; 22(5): e51532, 2021 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822458
7.
Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw: Japanese Osteoporosis Intervention Trial-05 (JOINT-05).
J Bone Miner Metab
; 41(6): 854-864, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897672
8.
Relationship Between Changes in Serum Levels of Intact Parathyroid Hormone and Sclerostin After a Single Dose of Zoledronic Acid: Results of a Phase 1 Pharmacokinetic Study.
Calcif Tissue Int
; 110(1): 87-92, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34427705
9.
Acute Phase Reactions After Intravenous Infusion of Zoledronic Acid in Japanese Patients with Osteoporosis: Sub-analyses of the Phase III ZONE Study.
Calcif Tissue Int
; 109(6): 666-674, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34247263
10.
Risk factors for incident vertebral fractures in osteoporosis pharmacotherapy: a 2-year, prospective, observational study.
J Bone Miner Metab
; 39(4): 668-677, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33738617
11.
Complication rate, cure rate, and long-term outcomes of microsurgery for intracranial dural arteriovenous fistulae: a multicenter series and systematic review.
Neurosurg Rev
; 44(1): 435-450, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31897884
12.
Impact of bone mineral density in reducing fracture risk in patients receiving alendronate plus alfacalcidol therapy.
J Orthop Sci
; 26(6): 1085-1093, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33358235
13.
Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with Osteoporosis.
Calcif Tissue Int
; 107(6): 559-566, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839843
14.
Efficacy of denosumab co-administered with vitamin D and Ca by baseline vitamin D status.
J Bone Miner Metab
; 38(6): 848-858, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32671481
15.
Changes in quality of life in patients with postmenopausal osteoporosis receiving weekly bisphosphonate treatment: a 2-year multicenter study in Japan.
J Bone Miner Metab
; 37(2): 273-281, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29523963
16.
Incidence of osteonecrosis of the jaw in Japanese osteoporosis patients taking minodronic acid.
J Bone Miner Metab
; 37(5): 886-892, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30719580
17.
Study design of multi-center, open-label randomized controlled, head-to-head trial comparing minodronic acid and raloxifene: Japanese Osteoporosis Intervention Trial (JOINT)-04.
J Bone Miner Metab
; 37(3): 491-495, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30019249
18.
A Pilot Study on Measuring Tissue Motion During Carotid Surgery Using Video-Based Analyses for the Objective Assessment of Surgical Performance.
World J Surg
; 43(9): 2309-2319, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31041560
19.
Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study.
J Bone Miner Metab
; 36(3): 336-343, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389932
20.
Effect of monthly intravenous ibandronate injections on vertebral or non-vertebral fracture risk in Japanese patients with high-risk osteoporosis in the MOVER study.
J Bone Miner Metab
; 35(1): 58-64, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26614597